Home › NDC Lookup › Ingredients › Oxyquinoline Sulfate And Sodium Lauryl S... › 59365-5030-00
💊image loading
(from DailyMed)

TRIMO SAN Oxyquinoline Sulfate and Sodium Lauryl .25 mg/g; .1 mg/g Jelly, 113.4 g — NDC 59365-5030-0 (Billing 59365-5030-00)

by CooperSurgical, Inc. · 113.4 g in 1 TUBE

This is a package of 113.4 g of TRIMO SAN Oxyquinoline Sulfate and Sodium Lauryl .25 mg/g; .1 mg/g Jelly from CooperSurgical, Inc., marketed since Apr 1977 and currently FDA-listed, this package's marketing is listed to end Oct 2026; retail pharmacies pay about $0.2431 per g (NADAC). It is this product's only package size.

NDC 59365-5030-00
🏷️ FDA NDC (as labeled) 59365-5030-0 billing pads the package segment with a zero
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 59365-5030-0 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
59365 labeler · 5030 product · 0 package
Package marketed since
Apr 1, 1977
Package marketing ended
Oct 31, 2026
Sample package
No — commercial package
Billing quantity
113 g per package
Barcode (UPC-A, from the NDC)
3 5936550300 9
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59365-5030-0
Product NDC 59365-5030
11-digit billing NDC 59365503000
NCPDP billing unit GM — per gram (weight)
RxCUI 999638, 999640
UNII 61VUG75Y3P, 368GB5141J
SPL Set ID 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1977-04-01
Marketing end 2026-10-31
Route VAGINAL
Dosage form JELLY
Substance OXYQUINOLINE SULFATE; SODIUM LAURYL SULFATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 55409902504020
GPI class Trimo-San
GCN Seq No 065662
GCN 27679
HICL code 036655
Ingredient (HICL) Oxyquinoline/Sod.lauryl Sulfat
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q4
Therapeutic class — intermediate (HIC2) Vaginal Preparations
HIC3 code Q4B
Therapeutic class — specific (HIC3) Vaginal Antiseptics
AHFS code 84:04.92.00
AHFS class Local Anti-Infectives, Miscellaneous
FDB label name TRIMO-SAN JELLY
FDB brand name Trimo-San
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 065662
  • GCN: 27679
  • GPI-14 (Medi-Span): 55409902504020
  • HICL (First Databank): 036655
  • AHFS class code: 84:04.92.00
  • RxCUI (RxNorm): 999638
Why two NDCs? The FDA registers this code as 59365-5030-0 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 59365-5030-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiinfectives and antiseptics for local oral treatment class.

Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Quinoline derivatives, Quinoline derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TRIMO-SAN JELLY Ingredient Oxyquinoline/Sod.lauryl Sulfat
🧪 What is this product?

Trimo San is a vaginal jelly containing oxyquinoline sulfate and sodium lauryl sulfate. Oxyquinoline sulfate is an antimicrobial agent typically used in vaginal products to help reduce certain bacteria and microorganisms. Sodium lauryl sulfate functions as a cleansing and emulsifying ingredient commonly found in topical vaginal preparations. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.243 $27.57 / 113.4 g
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Feb 2021 Oct 2022 Feb 2024 Jan 2026 $0.243 $0.195
▲ Up 25% over the last 6 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59365-5030-00 You're viewing this Main listing 113.4 g in 1 TUBE 1977-04-01 Oct 31, 2026 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Trimo San .25 mg/g; .1 mg/gthis 59365-5030-00 CooperSurgical, 113.4 g $0.243 — Availability likely —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1977
On the market since
Apr 1977
📍
2026
Currently FDA-listed
49 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII 9O3K93S3TK
    Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.

4 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCooperSurgical, Inc.
Labeler code59365
First marketedApr 1977
Product typeHuman Prescription Drug
Portfolio3 products on file

More NDCs from CooperSurgical, Inc. labeler code 59365

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
⚠️ Warnings 🤰 Pregnancy 📦 Storage and Handling 📋 Description 💬 Information for Patients 📄 Package Label / Principal Display Panel
⚠️ Warnings 51 words ▾

W ARNING: Chemicals in various preparations can interact with the pessary material resulting in discoloration or deterioration of the pessary. TRIMO-SAN does not have a deleterious effect on any Milex pessary. Testing should be performed before using any other vaginal preparation with a pessary unless specifically prescribed by your healthcare professional.

🤰 Pregnancy 64 words ▾

TRIMO-SAN and PREGNANCY TRIMO-SAN has NOT been tested for use during pregnancy. CooperSurgical does not recommend the use of TRIMO-SAN during pregnancy. If you wish to become pregnant, do not use TRIMO-SAN or any other personal hygiene product vaginally (douches, vaginal sprays, jellies or suppositories), for 6 hours prior to or following intercourse. Any product used within this time period could interfere with conception.

📦 Storage and Handling 20 words ▾

STORAGE: AFTER EACH USE Wipe threads of tube and the inside of the cap. RE-CAP TIGHTLY. Store at room temperature.

📋 Description 37 words ▾

P URPOSE OF TRIMO-SAN 1. To help restore and maintain normal vaginal acidity. 2. To coat walls of vagina with a lubricating film that may help reduce odor-causing bacteria, since bacteria can flourish in abnormal vaginal pH.

💬 Information for Patients 51 words ▾

INFORMATION ABOUT TRIMO-SAN 1. TRIMO-SAN Gel will not stain skin or natural fabrics. 2. TRIMO-SAN Gel helps eliminate odors, which may be associated with wearing a pessary. 3. Dosage of TRIMO-SAN Gel may be adjusted from one-half an applicator to a full applicator to obtain the desired results without messy leakage.

📄 Package Label / Principal Display Panel 52 words ▾

PRINCIPAL DISPLAY PANEL NDC 59365-5030-0 TRIMO-SAN VAGINAL JELLY SET with Universal Applicator CONTENTS: 1 ea. 4 oz tube (113. 4 grams) and applicator Rx Only Revised: 4/2024 PRINCIPAL DISPLAY PANEL NDC 59365-5030-0 TRIMO-SAN VAGINAL JELLY SET with Universal Applicator CONTENTS: 1 ea. 4 oz tube (113. 4 grams) and applicator Rx Only

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TRIMO SAN (this brand).

Top reported reactions

Fatigue4
Death3
Dyspnoea3
Hot Flush3
Urinary Tract Infection3
Abdominal Pain2
Acute Kidney Injury2

Age at onset

Adult1
Elderly10

Reporter sex

33 reports
Male · 6%
Female · 94%

Serious outcomes

Hospitalization8
Death5
Disabling1
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but CooperSurgical, Inc. has reported a marketing end date of 2026-10-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
CooperSurgical, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59361-0005-01 · Juzen 59365-5128-01 · CooperSurgical, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.